CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis

Background: CD161 is a promising immune checkpoint mainly expressed on natural killer (NK) cells and is essential for immunoregulatory functions. However, it remains obscure how CD161 correlates with immune infiltration and patient prognosis in pan-cancer. Methods: We employed HPA, TCGA, GTEx, TIMER...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Wenrui, Luo, Cong, Li, Chenglong, Liu, Zhixiong, Liu, Fangkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489134/
https://www.ncbi.nlm.nih.gov/pubmed/34659549
http://dx.doi.org/10.7150/jca.63236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489134/
https://www.ncbi.nlm.nih.gov/pubmed/34659549
http://dx.doi.org/10.7150/jca.63236

Ejemplares similares